
Theranica
Theranica develops prescription digital therapeutics, including the Nerivio wearable for drug-free migraine treatment.
- Private company
- Bridgewater, NJ, USUnited States

Theranica develops prescription digital therapeutics, including the Nerivio wearable for drug-free migraine treatment.
theranica.comCrawled Oct 15, 2026
Nerivio A drug-free migraine treatment I’m a patient I’m a healthcare professional The information in this section is intended for U.S. healthcare professionals continue cancel
The page describes migraine as a type of headache that causes throbbing pain, often on one side of the head, and can also cause nausea, vomiting, and sensitivity to light and sound.
CNBC TV 18 reviewed Dr Reddy’s Nerivio migraine device, describing it as a prescription, USFDA-approved, pulse-based treatment using remote electrical neuromodulation. The review notes variable efficacy and benefits for severe attacks.
Theranica says its mission is to change how patients with prevalent medical conditions treat and manage their diseases.
The page reports that non-systemic treatment may relieve migraine headaches, which affect an estimated 12% of Americans, and quotes Dr. Teshamae Monteith on a study involving adolescents.
The company develops wearable therapeutic products for pain treatment, combining neuroscience research with technology.
Theranica offers assistance with migraine symptoms through an online inquiry form, with a representative contacting users.
Theranica develops digital therapeutics for neurological pain diseases and uses a pain inhibition mechanism called Conditioned Pain Modulation (CPM).
Theranica Bio-Electronics Ltd.’s Terms of Use describe legal rights and obligations concerning the Theranica website and its services.